Abdulrahim, D. (2001), Substance misuse and mental health co-morbidity (dual diagnosis). Standards for mental health services, The Health Advisory Service: London.

Andreasen, J. (2002), Ansvaret for de psykotivke stofmisbrugere skal vara psykiatriens. Ugeskrift for læger, 51.

AST/RELIS (2002), Point Focal OEDT Luxembourg – Direction de la Santé. Réseau National d’Information sur les Drogues et les Toxicomanies – RELIS -– Rapport National, PFN: Luxembourg.

Bakken, K., Landheim, S. and Vaglum, P (2003), Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders? Alcohol and Alcoholism 38, pp. 54–9.

Barrowclough, C., Haddock, G., Tarrier, N., et al. (2001), Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with co-morbidity schizophrenia. American Journal of Psychiatry 158, pp. 1706–13.

Baudis, R. (2004), A drug court type project for juvenile drug-related offenders in Germany. Conference’s Acts: Substance Abuse, Drug Courts and Mental Health Treatment Services,. Servizi Area Penale Carceri, Milan, 5–7 February 2004.

Beck, F. (2003), Dépistage de l’usage problématique de cannabis: échelle et référence (draft report), ESCAPAD, OFDT: Paris,

Beck, F. and Legleye, S. (2003), Drogues et adolescence: usages de drogues et contextes d’usage entre 17 et 19 ans – évolutions récentes, ESCAPAD 2002, Paris: OFDT.

Benschop, A., Rabes, M. and Korf, D. (2002), Pill testing – ecstasy and prevention. A scientific evaluation in three European cities, Rozenberg Publishers: Amsterdam.

Berglund, M. et al. (ed.) (2003), Treating alcohol and drug abuse. An evidence-based review, Wiley: London.

Berthel, T. (2003), Psychiatrische Komorbidität, in: Beubler, E., Haltmayer, H. and Springer, A. (eds) Opiatabhängigkeit. Interdisciplinäre Aspekte für die Praxis, Springer: Vienna.

Best, D., Lan-Ho, M., Zador, D., et al. (2000), Overdosing on opiates. Thematic review. Part I – causes. Drug and Alcohol Findings, Issue 4, pp. 4–20.

Best, D., Lan-Ho, M., Zador, D., et al. (2001), Overdosing on opiates. Thematic review. Part II – prevention. Drug and Alcohol Findings, Issue 5, pp. 4–18.

Beutel, M. (1999), Sucht und sexueller Missbrauch. Psychotherapeut 44, pp. 313–19.

Bird, S. and Rotily, M. (2002), Inside methodologies for counting blood-borne viruses and injector-inmates’ behavioural risks – results from European prisons. Howard Journal 41 (2).

Bovenkerk, F. and Hogewind, W. I. M. (2002), Hennepteelt in Nederland: het probleem van criminaliteit en haar bestrijding. Utrecht: Willem Pompe Instituut voor Strafrechtswetenschappen.

Bronisch, T. and Wittchen, H.-U. (1998), Komorbidität von suizidalem Verhalten, Sucht, Depression und Angststörungen. Suizidprophylaxe 1, pp. 22–6.

Chinman, M., Imm, P. and Wandersmann, A. (2004), Getting to outcomes 2004. Promoting accountability through methods and tools for planning, implementation, and evaluation, RAND Corporation: Santa Monica.

CND (2004), World drug situation with regard to drug trafficking: report to the Secretariat, United Nations, Economic and Social Council: Vienna.

Commonwealth Department for Health and Ageing (2003), National Co-morbidity Project. Current practice in the management of clients with co-morbidity mental disorders and substance use disorders in tertiary care settings, Commonwealth of Australia: Canberra.

Crawford, V. (2001), Co-existing problems of mental health and substance misuse (‘dual diagnosis’): a review of relevant literature, Royal College of Psychiatrists: London.

Currie, C., Roberts, C., Morgan, A., et al. (2004), Young people's health in context. Health behaviour in school-aged children’, (HBSC) study: international report from the 2001/2002 survey, Health Policy for Children and Adolescents, No.4, Geneva: WHO Europe.

Deehan, A. and Saville, E. (2003), Calculating the risk: recreational drug use among clubbers in the South East of England, Home Office Online Report 43/03.

Department of Health (2002a), Mental health policy implementation guide: dual diagnosis good practice guide, Department of Health: London.

Department of Health (2002b), Models of care for substance misuse treatment: promoting quality, efficiency and effectiveness in drug misuse treatment services. Full report for consultation, Department of Health: London.

Dialog (2000), Jahresbericht 1999. Verein Dialog – Hilfs- und Beratungsstelle für Suchtgiftgefährdete und deren Angehörige, Vienna.

Dolan, K. (1997–98), Evidence about HIV transmission in prisons. Canadian HIV-AIDS Policy and Law Newsletter 3–4, pp. 32–8.

Dolan, K., Rutter, S. and Wodak, A. D. (2003), Prison-based syringe exchange programmes: a review of international research and development. Addiction 98, pp. 153–58.

Drake, R., Mercer-McFadden, C., Mueser, K., et al. (1998), Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin 24, pp. 589–608.

DrugScope (2004), Druglink 19 (1) Jan/Feb 2004.

Dusenbury, L. and Falco, M. (1995), Eleven components of effective drug abuse prevention curricula. Journal of School Health 65, pp. 420–5.

Eland, A. and Van de Glint, G. (2001), Diagnostiek en behandeling van ADHD binnen de intramurale verslavingszorg, Trimbos Instituut: Utrecht.

EMCDDA (2001), Cocaine and crack (special issue). In Annual report 2001: the state of the drugs problem in the acceding and candidate countries to the European Union, European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

EMCDDA (2003a), Annual report 2003: the state of the drugs problem in the acceding and candidate countries to the European Union, European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

EMCDDA (2003b), Annual report 2003: the state of the drugs problem in the European Union and Norway, European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

EMCDDA (2003c), Drugs in focus no. 11: Hepatitis C: a hidden epidemic, European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

EMCDDA (2003d), The international profile of cannabis clients, expert meeting on treatment demand – meeting with International organisations, Lisbon, 24 June 2003.

EMCDDA (2004a) European report on drug consumption rooms, European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

EMCDDA (2004b), Drugs in focus no. 13: Deaths. European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

EMCDDA (2004c), An overview of cannabis potency in Europe, EMCDDA Insights 6. European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

EMCDDA (2004d), Hepatitis C and injecting drug use: impact, costs and policy options. EMCDDA Monographs 7. European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

Emmanuelli, J. (2003), Siamois: Tendances en matière de réduction des risques chez les usagers de drogues par voie iv. In: Bello, J.-Y., Toufik, A., Gandilhon, M., et al. (eds) Phénomènes émergents liés aux drogues en 2002, quatrième rapport national du dispositif TREND, pp. 263–7. OFDT: Paris.

Estebanez, P., Russell, N. K., Aguilar, M.D., et al. (2001), Determinants of HIV prevalence amongst female IDU in Madrid. European Journal of Epidemiology 17, pp. 573–80.

European Centre for the Epidemiological Monitoring of AIDS (EuroHIV) (2004), HIV/AIDS Surveillance in Europe, End-year report, 2003, No. 70. Saint-Maurice: Institut de Veille Sanitaire.

European Commission (1999), Evaluating socio-economic programmes: glossary of 300 concepts and technical terms, Luxembourg: Office for Official Publications of the European Communities.

European Commission (2003), Evaluating EU activities – a practical guide for Commission Services, Luxembourg: Office for the Official Publication of the European Communities.

Europol (2002), Serious crime overviews: counter money laundering, a European Union perspective, Europol: The Hague.

Europol (2003), European Union organised crime report, Europol: The Hague.

Facy, F. (1999), Toxicomanes et prescription de méthadone, EDK: Paris.

Farrell, M. (2002), Final Evaluation of the Pilot Drug Court, Courts Service: Dublin.

FATF (2003a), Annual report 2002–2003.

FATF (2003b), Combating the abuse of alternative remittance systems: international best practices, FATF: Paris.

Flay, B. (2000), Approaches to substance use prevention utilizing school curriculum plus social environment change. Addictive Behaviours 25, pp. 861–6.

Fridell, M. (1991), Personlighet och drogmissbruk. En forskningsöversikt. PM-serie 10, Centralförbundet för alkohol- och narkotikaupplysnings (CAN), Stockholm.

Fridell, M. (1996), Psykisk störning och narkotikamissbruk. Socialstyrelsen. Psykiskt störda missbrukare. SoS-rapport 1996: 14, Socialstyrelsen: Stockholm.

Gerdner, A. (2004), Utfall av LVM-vård: översikt och syntes av hittilsvarande studier. Bilaga 4 till LVM-utredningen, SOU 2004: 3 Tvång och förändring – Rättssäkerhet, vårdens innehåll och eftervård, Socialdepartementet: Stockholm.

GFATM Secretariat (2004), The Global Fund Grant status report.

Giuliani, M. and Suligoi, B (2004), Italian STI Surveillance Working Group. Differences between nonnational and indigenous patients with sexually transmitted infections in Italy and insight into the control of sexually transmitted infections. Sexually Transmitted Diseases 31(2), pp. 79–84.

Gore, S.M. (1999), Fatal uncertainty: death-rate from use of ecstasy or heroin. Lancet 354, pp. 1265–6.

Hall, W., Degenhardt, L. and Lynskey, M (2001), The health and psychological effects of cannabis use, Monograph Series no. 44, 2nd edn, Commonwealth of Australia: Canberra.

Hannon F., Keleher C., and Friel, S. (2000), General healthcare study of the Irish prison population. Stationery Office: Dublin.

Hansen, W. (1992), School-based substance abuse prevention: a review of the state of the art in curriculum, 1980–1990. Health Education Research 7, pp. 403–30.

Hibell, B., Andersson, B., Ahlstrom, S., et al., (2000), The 1999 ESPAD Report: The European School Survey Project on Alcohol and Other Drugs. The Swedish Council for Information on Alcohol and Other Drugs (CAN) and Council of Europe, Pompidou Group.

Hope, V., Ncube, F., de Souza, L., et al. (2004), Shooting up: infections in injecting drug users in the United Kingdom, 2002. Eurosurveillance Weekly 8(4): 22 January 2004.

INCB (2004a), Report of the International Narcotics Control Board 2003, United Nations, INCB: New York.

INCB (2004b), Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, United Nations, INCB: New York.

Interpol (2002), Activities report, Interpol: Lyon.

Jansson, I. and Fridell, M. (2003), Psykisk och somatisk belastning hos tvångsvårdade kvinnor, LVM och LVU-vårdade kvinnor vid Lunden, SiS-rapport 1/03. Statens Institutionsstyrelse: Stockholm.

Joint Meeting of the Faculty of Substance Misuse of the Royal College of Psychiatrists and the World Psychiatric Association (2003), Innovations in the treatment of addiction, Barcelona, 1–2 May 2003.

Jonsson, S. (2001) Långstorps vård- och behandllingshem – En ufallsstudie. Psykologexamensuppsats Vol. III:20, Institutionen för psykologi: Lund.

Kessler, R. C., Aguilar-Gaxiola, S., Andrade, L., et al. (2001), Mental-substance comorbidities in the ICPE surveys. Psychiatrica Fennica 32, pp. 62–79.

Kokkevi, A. and Facy, F. (1995), Personality traits and psychopathology in drug addiction. European Addiction Research 1, pp. 194–8.

Kokkevi, A. and Stefanis, C. (1995), Drug abuse and psychiatric co-morbidity. Comprehensive Psychiatry 36, pp. 329–37.

Kraus, L., Augustin, R., Korf, D., et al. (2003), Cannabis use in France, Germany, Greece and Spain: has age of first use experience shifted towards younger age? (report).

Krausz, M. (1996), Old problems – new perspectives. European Addiction Research 2, pp. 1–2.

Krausz, M. (1999a), Editorial. Addiction and mental health. European Addiction Research 5, pp. 53–4.

Krausz, M. (1999b), Komorbidität – Psychische Störungen bei Schwerstabhängigen; Forschungsstand und klinische Konsequenzen. In: Bellebaum, C. Jellinek, and Westermann, B. (eds) Mehr als Abhängig? Versuche mit Methadon und Heroin, pp. 100–14. Deutscher Studienverlag: Weinheim.

Krausz, M., Verthein, U. and Degkwitz, P. (1999), Psychiatric co-morbidity in opiate addicts. European Addiction Research 5, pp. 55–62.

Landheim, A. S., Bakken, K. and Vaglum, P. (2003), Gender differences in the prevalence of symptom disorders and personality disorders among poly-substance abusers and pure alcoholics, European Addiction Research 9, pp. 8–17.

Lauritzen, G., Waal, H., Amundsen, A. and Arner, O. (1997), A nationwide study of Norwegian drug abusers in treatment: methods and findings. Nordisk alkohol- & narkotikatidsskrift 14, pp. 43–63.

Ley, A., Jeffery, D. P., McLaren, S. and Siegfried, N. (2003), Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Review. The Cochrane Library, Issue 4, Wiley: Chichester, UK.

Liappas, J. (2001), Drug addiction: a multidimensional therapeutic problem. Itaca 6, pp. 9–22.

Lima, A. R., Lima, M. S., Soares, B. G. O. and Farrell, M. (2004a), Carbamazepine for cocaine dependence. Cochrane Review. The Cochrane Library, Issue 2, 2004.

Lima, M. S., Reisser, A. A. P., Soares, B. G. O., Farrell, M. (2004b), Antidepressants for cocaine dependence. Cochrane Review. The Cochrane Library, Issue 2, 2004.

Long, J., Allwright, S. and Begley, C. (2004), Prisoners’ views of injecting drug use and harm reduction in Irish prisons. International Journal of Drug Policy, in press.

Marsden, J., Gossop, M., Stewart, D., et al. (2000), Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment outcome study. British Journal of Psychiatry 176, pp. 285–9.

McIntosh, C. and Ritson, B (2001), Treating depression complicated by substance misuse. Advances in Psychiatric Treatment 7, pp. 357–64.

McVeigh, J., Beynon, C. and Bellis, M. A. (2003), New challenges for agency based exchange schemes: analysis of 11 years of data (1991–2001) in Merseyside and Cheshire, United Kingdom. International Journal of Drug Policy 14, pp. 399–405.

Mears, A., Clancy, C., Banerjee, S., et al. (2001), Co-existing problems of mental disorder and substance misuse (dual diagnosis): a training needs analysis, Royal College of Psychiatrists: London.

Migliori, G.B. and Centis, R. (2002), Problems to control TB in eastern Europe and consequences in low incidence countries. Monaldi Archive of Chest Diseases 57, pp. 285–90.

Morel, A. (1999), Troubles psychiatriques associés à la toxicomanie. Interventions 72, pp. 35–40.

Moyle, P. (2003), International drug court developments, models and effectiveness, Pompidou Group Drug Court Project: Strasbourg.

Murphy-Lawless, J. (2002), Fighting back: women and the impact of drug abuse on families and communities, Liffey Press: Dublin.

Murray, R., Grech, A., Phillips, P. and Johnson, S. (2003), What is the relationship between substance abuse and schizophrenia? In: Murray, R., Jones, P., Susser, E., et al. (eds), The epidemiology of schizophrenia, Cambridge University Press: Cambridge.

Neale, J. and Robertson, M. (2004), Recent cocaine and crack use among new drug treatment clients in Scotland. Drugs: Education, Prevention and Policy 11(1), pp. 79–90.

Nestler, E. J. (2001), Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience 2(2):119–28.

Öjehagen, A. and Schaar, I. (2003) Mentally ill substance abusers in Sweden: a 5-year follow-up of a multisite study of co-operation between psychiatric services and social authorities. In: Carrà, G. and Clerici, M. (eds) Dual diagnosis: filling the gap, John Libbey Eurotext: Paris.

Olin, N. and Plasait, B. (2003), Drogue: l’autre cancer. Rapport de la Commission d’enquête sur la politique nationale de lutte contre les drogues illicites. Sénat: Paris.

Origer, A. and Delucci, H. (2002), Etude épidemiologique et méthodologique des cas de décès liés à l’usage illicite des substances psycho-actives. Analyse comparative (1999–2000), Séries de recherche no. 3, Point focal OEDT Luxembourg-CPR Santé: Luxembourg.

Paglia, A. and Room, R. (1999), Preventing substance use problems among youth: a literature review and recommendations. Journal of Primary Prevention 20(1), pp. 3–50.

Pani, P. P., Trogu, E., Carboni, G., et al. (2003), Psychiatric severity and treatment response in methadone maintenance treatment programmes: new evidence. Heroin Addiction & Related Clinical Problems 5, pp. 23–36.

Pedersen, M. U. (2001), Substitutionsbehandling. Organiseringer, stofmisbrugere, effekter, metoder. Del 1. Center for Rusmiddelforskning, Aarhus Universitet: Århus.

Popov, P. (2003), Alkohol. In: Kalina, K. a spol. (ed.) Drogy a drogové závislosti – mezioborový přístup, Kapitola 3/1, Praha: Úřad vlády ČR - NMC.

Ravelli, A., Bijl, R. V. and Van Zessen, G. (1998), Comorbiditeit van psychiatrische stoornissen in de Nederlandse bevolking; resultaten van de Netherlands Mental Health Survey and Incidence Study (NEMESIS). Tijdschrift voor Psychiatrie 40, pp. 531–44.

Reitox national reports (2003).

Rhodes, T., Lilly, R., Fernández, C., et al. (2003), Risk factors associated with drug use: the importance of ‘risk environment’. Drugs: Education, Prevention and Policy 10, pp. 303–29.

Roeg, D. P. K., van de Goor, L. A. M. and Garretsen, H. F. L. (2004) When a push is not a shove: assertive care, Dutch-style. Drugs and Alcohol Today , Vol. 4 (in press).

Rooney, S., Kelly, G., Bamford, L., et al. (1999), Co-abuse of opiates and benzodiazepines. Irish Journal of Medical Science 168: 36–41.

SAMHSA, Office of Applied Studies (2001), Trends in initiation of substance use, 2001 National Household Survey on Drug Abuse (NHSDA).

SAMHSA, Office of Applied Studies (2002), Results from the 2002 National Survey on Drug Use and Health. National findings.

Schifano, F., Oyefeso, A., Corkery, J., et al. (2003), Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002. Human Psychopharmacology and Clinical Exposure 18, pp. 519–24.

Seivewright, N., Donmall, D., Douglas, J., et al. (2000), Cocaine misuse treatment in England. International Journal of Drug Policy 11, pp. 203–15.

Siliquini, R., Zeppegno, P. and Faggiano, F. (2002), Patologia psichiatrica e consumo di sostanze: descrizione preliminare dei casi di uno studio caso–controllo. In: Faggiano, F. (ed.) OED Piemonte – Rapporto 2002, Turin: Osservatorio Epidemiologico Dipendenze.

Sosial- og helsedepartementet (1999), Rapportane I, II, III, frå Arbeidsgruppa for å gjennomgå hjelpe- og behandlingstilbodet for rusmiddelmisbrukarar.

Springer, A. (2003a) Different types of medically assisted treatment. Treatment monitoring conference, EMCDDA, Lisbon.

Springer, A. (2003b), Psychotherapeutische Aspekte. In: Beubler, E., Haltmayer, H. and Springer, A. (eds) Opiatabhängigkeit. Interdisziplinäre Aspekte für die Praxis, Springer: Vienna.

Stothard, B., and Ashton, M. (2000), Education’s uncertain saviour. Drug and Alcohol Findings 3, pp. 4–7, 16–20.

Stöver, H. (2001), Bestandsaufnahme ‘Crack Konsum’ in Deutschland: Verbreitung, Konsummuster, Risiken und Hilfeangebote. Endbericht. Bremen: University of Bremen, Institute for Drugs Research (BISDRO).

Stöver, H. and Nelles, J. (2003), Ten years of experience with needle and syringe exchange programmes in European prisons. International Journal of Drug Policy 14, pp. 437–44.

Ter Bogt, T. and Engels, R. C. M. E. (2004). Party style: notice for and effects of MDMA at Rave parties. Substance Use and Misuse (in press).

Tobler, N. (2001), Prevention is a two-way process. Drug and Alcohol Findings, Issue 5, pp. 25–7.

Tobler, N. and Stratton H.H. (1997), Effectiveness of school-based drug prevention programs: a meta-analysis of the research. Journal of Primary Prevention 18(1), pp. 71–128.

Tobler, N. S., Roona, M. R. and Ochshorn, P. (2000), School-based adolescent prevention programs: 1998 meta-analysis. Journal of Primary Prevention 20: pp. 275–336.

Uchtenhagen, U. and Zeiglgänsberger, W. (2000), Suchtmedizin – Konzepte, Strategien und therapeutisches Management, Urban & Fischer Verlag: Munich.

UNODC (2003a), Global illicit drug trends 2003, United Nations Office on Drugs and Crime, Vienna.

UNODC (2003b), Ecstasy and amphetamines: global survey 2003, United Nations Office on Drugs and Crime, Vienna.

UNODC and Government of Morocco (2003), Morocco cannabis survey 2003. United Nations Office on Drugs and Crime: Vienna.

UNODCCP (United Nations Office for Drug Control and Crime Prevention) (2000), Demand reduction: a glossary of terms, United Nations: New York.

Vaglum, P. (1996) Psychopathology and substance abuse: clinical Lessons from six Norwegian Studies. Psychiatric Fennica 27: 55–67.

Van den Bosch, L. M., Verheul, R. and Van den Brink, W. (2001), Substance abuse in borderline personality disorder: clinical and etiological correlates. Journal of Personality Disorders 15, pp. 416–24.

Van Rooijen, M. (2001), Zendingswerk: dubbele diagnose kliniek. Psy 5, pp. 24–8.

Verheul, R. (2001), Co-morbidity of personality disorders in individuals with substance use disorders. European Psychiatry 16, pp. 274–82.

WCO (2003a), Drug routes from Central Asia to Europe (available on the WCO web site.

WCO (2003b), An integrated international response to drug smuggling. WCO: Brussels.

WCO (2003c) World money laundering report, Volume 4, Issue 10.

Weaver, T., Madden, P., Charles, V., et al. (2003), Co-morbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry 183, pp. 304–12.

WHO (1995), Lexicon of alcohol and drug terms, WHO: Geneva.

Wiessing, L. and Kretzschmar, M. (2003), Can HIV epidemics among IDUs ‘trigger’ a generalised epidemic? International Journal of Drugs Policy 14, pp. 99–102.

Williams, H., O’Connor, J. J. and Kinsella, A. (1990), Depressive symptoms in opiate addicts on methadone maintenance. Irish Journal of Psychological Medicine 7, pp. 45–6.

Wolf, J., Mensink, C., and Van der Lubbe, P. (2002), Casemanagement voor langdurig verslaafden met meervoudige problemen: een systematisch overzicht van interventie en effect. Ontwikkelcentrum Sociaal Verslavingsbeleid: Utrecht.

Zuckerman, J. (2003), The place of accelerated schedules for hepatitis A and hepatitis B vaccinations. Drugs 63, pp. 1779–84.

Zurhold, H., Kreutzfeldt, N., Degkwitz, P. and Verthein, U. (2001), Drogenkonsumräume. Gesundheitsförderung und Minderung öffentlicher Belastungen in europäischen Grossstädten. Lambertus: Freiburg.